We are live on ! Find out more
CCI

Columbus Circle Investors Portfolio holdings

AUM $2.28B
1-Year Est. Return 135.57%
This Fund
S&P 500
This Quarter Est. Return
+42.16%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
AUM
$2.28B
AUM Growth
-$16.7M
Cap. Flow
-$626M
Cap. Flow %
-27.41%
Top 10 Hldgs %
23.67%
Holding
200
New
34
Increased
29
Reduced
63
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 33.21%
2 Healthcare 21.46%
3 Consumer Discretionary 18.6%
4 Industrials 10.1%
5 Financials 6.65%

No holdings matched the selected filter criteria.

Similar funds

Columbus Circle Investors's Q4 2020 Portfolio in Review

As of Q4 2020, Columbus Circle Investors held 200 positions worth $2.28B, down 0.73% from $2.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Columbus Circle Investors withdrew a net $626M in Q4 2020, closing 74 positions and reducing 63 holdings. Its most notable exit was Fox Factory Holding Corp, an estimated $36M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Columbus Circle Investors opened a new position in Ambarella worth $43.9M.

  • Columbus Circle Investors's largest Q4 2020 buy was Ambarella: 478,388 shares worth $43.9M.
  • Columbus Circle Investors added most to Anaplan, Inc. in Q4 2020, an estimated $31.3M increase.
  • Columbus Circle Investors's biggest Q4 2020 reduction was Tandem Diabetes Care, cutting an estimated $26.9M.
  • Columbus Circle Investors fully exited Fox Factory Holding Corp in Q4 2020, selling an estimated $36M.
  • Columbus Circle Investors's ten largest holdings make up 24% of its $2.28B portfolio in Q4 2020.
  • Columbus Circle Investors opened 34 new positions and closed 74 in Q4 2020.
  • Columbus Circle Investors's portfolio value fell 0.73% quarter-over-quarter to $2.28B.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.